FSD Pharma Inc. (HUGE)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 17.17M |
| Enterprise value | 14.00M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 105.03 |
| Price/book (mrq) | 1.34 |
| Enterprise value/revenue | 119.64 |
| Enterprise value/EBITDA | -0.89 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.91 |
| 52-week change 3 | -67.07% |
| S&P500 52-week change 3 | 24.19% |
| 52-week high 3 | 1.6800 |
| 52-week low 3 | 0.4180 |
| 50-day moving average 3 | 0.7034 |
| 200-day moving average 3 | 1.0045 |
Share statistics
| Avg vol (3-month) 3 | 174.32k |
| Avg vol (10-day) 3 | 298.94k |
| Shares outstanding 5 | 40.43M |
| Implied shares outstanding 6 | 44.6M |
| Float 8 | 34.34M |
| % held by insiders 1 | 17.37% |
| % held by institutions 1 | 2.53% |
| Shares short (15 Apr 2024) 4 | 373.99k |
| Short ratio (15 Apr 2024) 4 | 2.85 |
| Short % of float (15 Apr 2024) 4 | 1.08% |
| Short % of shares outstanding (15 Apr 2024) 4 | 0.93% |
| Shares short (prior month 15 Mar 2024) 4 | 436.57k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 16 Oct 2019 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:201 |
| Last split date 3 | 16 Oct 2019 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -43.02% |
| Return on equity (ttm) | -83.91% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -16.73M |
| Net income avi to common (ttm) | -17.9M |
| Diluted EPS (ttm) | -0.4600 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 3.51M |
| Total cash per share (mrq) | 0.09 |
| Total debt (mrq) | 339.2k |
| Total debt/equity (mrq) | 2.63% |
| Current ratio (mrq) | 2.43 |
| Book value per share (mrq) | 0.34 |
Cash flow statement
| Operating cash flow (ttm) | -10.83M |
| Levered free cash flow (ttm) | -15.51M |
© 2024 Yahoo. All rights reserved.